(Press-News.org) Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face.
Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.
While both drugs are known to protect hearing on their own, this is the first study to test the two in combination.
"We found they have synergy," says Jianxin Bao, PhD, research associate professor of otolaryngology at the School of Medicine. "Two drugs at lower dosages can block more signaling pathways than one alone, improving results while reducing side effects. We got the idea from cancer and HIV studies that use multiple drugs at lower dosages."
Bao presented the work Feb. 21 in Baltimore at a meeting of the Association for Research in Otolaryngology.
In earlier work, Bao's group found that anticonvulsant drugs for treating epilepsy helped protect hearing in mice after exposure to loud noise. And other groups had determined that glucocorticoids, anti-inflammatory drugs often used to treat allergies and asthma, were also protective.
The reasons these drugs reduce noise-induced hearing loss are not well understood. But anticonvulsants are known to block calcium channels in nerve cells, and Bao's group speculates that the drug helps protect neuronal connections between hair cells and auditory neurons.
For this work, Bao and colleagues chose two drugs from the anti-epilepsy family and two from the glucocorticoid family.
"We picked drugs that have fewer side effects and that can be chronically used," says Bao, also associate professor of audiology and communication sciences.
To test each drug's ability to prevent hearing loss, they gave various doses to mice two hours before exposing them to noise. To test treatment, they administered the drugs to different groups of mice 24 hours after noise exposure.
Three of the four drugs showed increasing protection with higher doses. And two of the drugs in combination, the anticonvulsant zonisamide and the glucocorticoid methylprednisolone, showed comparable hearing protection at much lower doses than when administered alone.
While the drugs do not prevent all hearing loss following sustained exposure to noise at 110 decibels, or about the sound of a chain saw, they can significantly reduce the loss by about 10 to 30 decibels.
In other words, a mouse with normal hearing might be able to hear a sound at 30 decibels. After exposure to loud noise, that mouse might only hear sounds that reach 50 decibels. But if that mouse were treated, it might be able to hear sounds at 40 decibels. In humans, protecting 5 or 10 decibels makes a difference in being able to hear everyday speech.
Bao says their next step is to test the drugs in animals that model human hearing more closely.
###
Bao et al. "Development of a combination therapy for noise-induced hearing loss." Presented Feb. 21, 2011 at a meeting of the Association for Research in Otolaryngology.
This work was supported by the National Institute on Deafness and Other Communication Disorders.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked fourth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
2 drugs protect hearing better than 1
2011-02-24
ELSE PRESS RELEASES FROM THIS DATE:
Iowa State, Ames Lab researchers describe the pump that bacteria use to resist drugs
2011-02-24
AMES, Iowa – A research team led by Edward Yu of Iowa State University and the Ames Laboratory has identified and described two parts of the three-part system that pumps toxins from bacteria and allows them to resist antibiotics.
The discoveries are published in the Feb. 24 issue of the journal Nature.
The paper describes the co-crystal structure of two parts of the three-part efflux pump that recognizes and removes heavy metal toxins from bacteria. A research team led by Yu – an Iowa State associate professor of physics and astronomy, of chemistry, of biochemistry, ...
Making solar panels with cleaner, greener technology
2011-02-24
Mention solar energy, and most people think "squeaky clean, pollution-free." The reality of making solar panels with existing technology, however, is much different, involving use of potentially toxic substances and lots of energy. That could change, according to an article in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
In the article, C&EN Associate Editor Sarah Everts describes the beginning of a scientific effort to manufacture solar panels in a way that better fits the public perception. Current silicon-based solar panels, ...
U of M researcher discovers stereotypes can deter consumer purchases
2011-02-24
The perception of negative stereotyping, particularly in the areas of financial services and automobile sales and service, can cause consumers to fear being duped and forgo their purchases, according to new research by University of Minnesota associate professor Kathleen D. Vohs.
Vohs, the Land O'Lakes Professor for Excellence in Marketing at the university's Carlson School of Management, and co-authors Hakkyun Kim (Concordia University, Canada) and Kyoungmi Lee (Yonsei University, Korea) found that a potential buyer, aware of negative associations held about a group ...
Whole fresh blood for transfusions may have a longer shelf life than now assumed
2011-02-24
In a finding that may potentially improve survival from war injuries and disasters, laboratory researchers report that refrigerated whole blood may have a shelf life well beyond the current standard of 24 to 48 hours.
"We have found that whole blood retains its clotting properties at least 11 days under standard refrigeration," said the study leader, David Jobes, M.D., a cardiothoracic anesthesiologist in the Cardiac Center at The Children's Hospital of Philadelphia. "If this lab discovery can be confirmed in human subjects, it may lead to a change in clinical practice, ...
New long-acting local anesthetic derived from algae effectively blocks pain in surgical patients
2011-02-24
Boston, MA -- A U.S.-Chile collaboration is bringing surgical patients closer to having a long-acting local anesthetic. In a randomized, double-blind trial, patients given neosaxitoxin, a new local anesthetic derived from algae, had significantly less postoperative pain and recovered about two days sooner than those given the commonly used local anesthetic bupivacaine. Based on this finding, Children's Hospital Boston, a co-investigator on the study, has signed a collaboration agreement with biotech start-up company Proteus SA (Santiago, Chile) to move the new anesthetic ...
Are we more -- or less -- moral than we think?
2011-02-24
A study by Rimma Teper, Michael Inzlicht, and Elizabeth Page-Gould of the University of Toronto Scarborough (UTSC) on human morality has just been published in Psychological Science, a journal of the Association of Psychological Science.
The study tested the difference between moral forecasting and moral action—and the reasons behind any mismatch. The findings look encouraging: people act more morally than they would have predicted.
But lest we get sentimental about that result, lead author and psychology PhD candidate Teper offers this: "There has been other work ...
New study confirms body weight influences risk of death among Asians
2011-02-24
A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.
The study, led by Wei Zheng, M.D., Ph.D., M.P.H., Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, Nashville, Tenn., Paolo Boffetta, M.D., M.P.H., professor, Mount Sinai School of Medicine, New York, N.Y., and John D. Potter, M.D., Ph.D., member ...
Bacteria living on old-growth trees
2011-02-24
A new study by Dr. Zoë Lindo, a post-doctoral fellow in the Department of Biology at McGill University, and Jonathan Whiteley, a doctoral student in the same department, shows that large, ancient trees may be very important in helping forests grow.
These findings highlight the importance of maintaining the large old-growth trees in the coastal temperate rainforests that stretch from Southern Alaska to Northern California. Lindo's findings suggest that it is the interactions between old trees, mosses and cyanobacteria, which contribute to nutrient dynamics in a way that ...
'Weird science' uncovered inside neutron star
2011-02-24
A University of Alberta astronomer has glimpsed the inner working of a neutron star and found a unique world where the physics can be described as "weird." Craig Heinke's team found the neutron star's core contained a superfluid, a friction-less liquid that could seemingly defy the laws of gravity.
"If you could put some of this superfluid in a jar it would flow up the walls of the container and over the edge," said Heinke.
Heinke says the core of the neutron star also contains a superconductor, a perfect electrical conductor. "An electric current in a superconductor ...
Discovery of new gene mutation in schizophrenia offers a new target for drug therapies
2011-02-24
In a major advance for schizophrenia research, an international team of scientists led by the University of California, San Diego School of Medicine and involving Trinity College Dublin researchers has identified a gene mutation strongly linked to schizophrenia that may be an important new target for the development of drug therapies. The findings are just published in the online issue of the journal Nature.
Schizophrenia is a chronic, severe and disabling brain disorder, with symptoms that include hallucinations, delusions and thought disorder. Schizophrenia is believed ...